Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Novel Diagnostic and Prognostic Biomarker Panel for Endothelial Cell Damage-Related Complications in Allogeneic Transplantation.
Tatekawa S, Kohno A, Ozeki K, Watamoto K, Ueda N, Yamaguchi Y, Kobayashi T, Yokota I, Teramukai S, Taniwaki M, Kuroda J, Morishita Y. Tatekawa S, et al. Among authors: ueda n. Biol Blood Marrow Transplant. 2016 Sep;22(9):1573-1581. doi: 10.1016/j.bbmt.2016.05.018. Epub 2016 May 28. Biol Blood Marrow Transplant. 2016. PMID: 27246373 Free article.
Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus.
Hirano D, Kato H, Kodaira T, Yatabe Y, Ueda N, Murakami S, Higuchi Y, Taji H, Nakamura S, Yamamoto K, Kinoshita T. Hirano D, et al. Among authors: ueda n. Ann Hematol. 2015 Jan;94(1):173-5. doi: 10.1007/s00277-014-2128-7. Epub 2014 Jun 20. Ann Hematol. 2015. PMID: 24947796 No abstract available.
Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Ueda N, Konuma T, Aoki J, Takahashi S, Ozawa Y, Mori T, Ota S, Eto T, Takada S, Yoshioka S, Shiratori S, Kako S, Onizuka M, Fukuda T, Kanda Y, Atsuta Y, Yanada M. Ueda N, et al. Transplant Cell Ther. 2021 Feb;27(2):185.e1-185.e6. doi: 10.1016/j.jtct.2020.10.018. Epub 2020 Dec 13. Transplant Cell Ther. 2021. PMID: 33830037 Free article.
Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells.
Zhang R, Liu TY, Senju S, Haruta M, Hirosawa N, Suzuki M, Tatsumi M, Ueda N, Maki H, Nakatsuka R, Matsuoka Y, Sasaki Y, Tsuzuki S, Nakanishi H, Araki R, Abe M, Akatsuka Y, Sakamoto Y, Sonoda Y, Nishimura Y, Kuzushima K, Uemura Y. Zhang R, et al. Among authors: ueda n. Cancer Immunol Res. 2015 Jun;3(6):668-77. doi: 10.1158/2326-6066.CIR-14-0117. Epub 2015 Feb 11. Cancer Immunol Res. 2015. PMID: 25672396
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.
Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, Sasaki Y, Shimoda R, Osako Y, Sawada Y, Kubo Y, Miyashita A, Fukushima S, Cheng Z, Nakaki R, Takubo K, Okada S, Kaneko S, Ihn H, Kaisho T, Nishimura Y, Senju S, Endo I, Nakatsura T, Uemura Y. Tsuchiya N, et al. Among authors: ueda n. Cell Rep. 2019 Oct 1;29(1):162-175.e9. doi: 10.1016/j.celrep.2019.08.086. Cell Rep. 2019. PMID: 31577946 Free article.
1,497 results